DANIEL PALMIERI: Open Payments
NPI 1811172448 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,877 in 118 payments from 21 companies in 2025. Trend: 2023 $2,224 · 2024 $2,364 · 2025 $2,877
Food & beverage: $2,877
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $481 |
| AstraZeneca Pharmaceuticals LP | 11 | $417 |
| Amgen Inc. | 19 | $364 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $219 |
| ABBVIE INC. | 15 | $207 |
| Lilly USA, LLC | 9 | $168 |
| INTUITIVE SURGICAL, INC. | 1 | $124 |
| PFIZER INC. | 5 | $114 |
| Abbott Laboratories | 5 | $110 |
| Exact Sciences Corporation | 5 | $99 |
Products named: Wegovy, BREZTRI, Kerendia, Ozempic, JARDIANCE, Da Vinci Surgical System, REXULTI, FARXIGA.
Industry payments across FL — which companies pay providers there.
